Nodular lymphocyte-predominant hodgkin lymphoma in a 15-year-old boy with li-fraumeni syndrome having a germline TP53 D49H mutation

Research output: Contribution to journalArticle

Abstract

Germline mutations in TP53 are the primary cause of Li-Fraumeni syndrome (LFS). Most mutations are reported within the DNA-binding domain. We report a case of a 15-year-old boy with LFS who developed early-stage nodular lymphocyte-predominant Hodgkin lymphoma, a rare subtype of Hodgkin lymphomas. His sister was diagnosed with embryonal rhabdomyosarcoma at the age of 1.5 years. Sequence analysis revealed a germline mutation in the transactivation domain of TP53, c.145G>C (p.D49H), in the patient, his sister, and father. One family with LFS with a germline TP53 D49H mutation has previously been reported. This report supports the pathogenicity of this mutation.

Original languageEnglish
Pages (from-to)e195-e197
JournalJournal of Pediatric Hematology/Oncology
Volume40
Issue number3
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Li-Fraumeni Syndrome
Hodgkin Disease
Germ-Line Mutation
Mutation
Siblings
Embryonal Rhabdomyosarcoma
Fathers
Transcriptional Activation
Sequence Analysis
Virulence
DNA

Keywords

  • Li-Fraumeni syndrome
  • nodular lymphocyte-predominant Hodgkin lymphoma
  • rituximab

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

@article{90226b0c22c0433d8a6ba2acb169962b,
title = "Nodular lymphocyte-predominant hodgkin lymphoma in a 15-year-old boy with li-fraumeni syndrome having a germline TP53 D49H mutation",
abstract = "Germline mutations in TP53 are the primary cause of Li-Fraumeni syndrome (LFS). Most mutations are reported within the DNA-binding domain. We report a case of a 15-year-old boy with LFS who developed early-stage nodular lymphocyte-predominant Hodgkin lymphoma, a rare subtype of Hodgkin lymphomas. His sister was diagnosed with embryonal rhabdomyosarcoma at the age of 1.5 years. Sequence analysis revealed a germline mutation in the transactivation domain of TP53, c.145G>C (p.D49H), in the patient, his sister, and father. One family with LFS with a germline TP53 D49H mutation has previously been reported. This report supports the pathogenicity of this mutation.",
keywords = "Li-Fraumeni syndrome, nodular lymphocyte-predominant Hodgkin lymphoma, rituximab",
author = "Fumito Yamazaki and Haruko Shima and Tomoo Osumi and Satoshi Narumi and Tatsuo Kuroda and Hiroyuki Shimada",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/MPH.0000000000000948",
language = "English",
volume = "40",
pages = "e195--e197",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Nodular lymphocyte-predominant hodgkin lymphoma in a 15-year-old boy with li-fraumeni syndrome having a germline TP53 D49H mutation

AU - Yamazaki, Fumito

AU - Shima, Haruko

AU - Osumi, Tomoo

AU - Narumi, Satoshi

AU - Kuroda, Tatsuo

AU - Shimada, Hiroyuki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Germline mutations in TP53 are the primary cause of Li-Fraumeni syndrome (LFS). Most mutations are reported within the DNA-binding domain. We report a case of a 15-year-old boy with LFS who developed early-stage nodular lymphocyte-predominant Hodgkin lymphoma, a rare subtype of Hodgkin lymphomas. His sister was diagnosed with embryonal rhabdomyosarcoma at the age of 1.5 years. Sequence analysis revealed a germline mutation in the transactivation domain of TP53, c.145G>C (p.D49H), in the patient, his sister, and father. One family with LFS with a germline TP53 D49H mutation has previously been reported. This report supports the pathogenicity of this mutation.

AB - Germline mutations in TP53 are the primary cause of Li-Fraumeni syndrome (LFS). Most mutations are reported within the DNA-binding domain. We report a case of a 15-year-old boy with LFS who developed early-stage nodular lymphocyte-predominant Hodgkin lymphoma, a rare subtype of Hodgkin lymphomas. His sister was diagnosed with embryonal rhabdomyosarcoma at the age of 1.5 years. Sequence analysis revealed a germline mutation in the transactivation domain of TP53, c.145G>C (p.D49H), in the patient, his sister, and father. One family with LFS with a germline TP53 D49H mutation has previously been reported. This report supports the pathogenicity of this mutation.

KW - Li-Fraumeni syndrome

KW - nodular lymphocyte-predominant Hodgkin lymphoma

KW - rituximab

UR - http://www.scopus.com/inward/record.url?scp=85044750589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044750589&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000000948

DO - 10.1097/MPH.0000000000000948

M3 - Article

VL - 40

SP - e195-e197

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 3

ER -